glp-1 news november 2025 today updates supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – GLP-1 RA prescription trends: January – glp-1 news november 2025 today

Many people using GLP-1 medications may find themselves with more energy and motivation to engage in physical activity as their appetite and cravings are more controlled

Mounjaro is approved by the FDA to treat type 2 diabetes while Zepbound is intended for weight management

However, as your body metabolizes it, the effects wear off, and your sleep becomes fragmented

Wegovy, Zepbound, Ozempic are names that have moved from prescription pads into everyday conversation, appearing in news headlines, social media feeds, and dinner table discussions with a speed that reflects just how much cultural weight we collectively attach to the question of body size

Womens Balance is formulated for women 45+ to support the key root causes of hair thinning for women, such as stress, with optimized support for hormonal changes, such as menopause, that affect hair health